NRX Pharmaceuticals, Inc.

Big Rock Partners Acquisition Corp. (Nasdaq: BRPA), sponsored by Big Rock Partners LLC, is a blank-check company that completed its IPO in 2019 targeting the healthcare and pharmaceutical sector. The June 2021 S-1 registration statement, filed under accession number 0001193125-21-200558, relates to the proposed business combination with NRX Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing treatments for life-threatening conditions including severe bipolar depression and critical COVID-19 illness. The filing marks a key step in BRPA's de-SPAC process, bringing NRX Pharmaceuticals to the public markets through the merger vehicle. Visit SpacDesk and sign up for full data, deal timelines, and filing analytics on BRPA and hundreds of other SPAC transactions.